Lecithin-based novel cationic nanocarriers (Leciplex) II: improving therapeutic efficacy of quercetin on oral administration.

The objective of the present investigation was to evaluate ability of the novel self-assembled phospholipid- based cationic nanocarriers (LeciPlex) in improving the therapeutic efficacy of a poorly water-soluble natural polyphenolic agent, quercetin (QR), on oral administration. Quercetin loaded LeciPlex (QR-LeciPlex) were successfully fabricated using a biocompatible solvent Transcutol HP. The QR-LeciPlex were characterized for particle size, encapsulation efficiency, zeta potential, and particle morphology by cryo-TEM. UV and fluorescence spectral characterization was carried out to find out the association of QR with LeciPlex. Small angle neutron scattering studies (SANS) were carried out to understand the internal structure of Leciplex and to evaluate the influence of the incorporation of QR in the LeciPlex. Anti-inflammatory and antitumorigenic activity of QR-LeciPlex was determined in comparison to QR suspension to evaluate the potential of LeciPlex in improving oral delivery of QR. QR-LeciPlex exhibited a particle size of ∼400 nm and had excellent colloidal stability. The QR-LeciPlex had a zeta potential greater than +30 mV and exhibited very high encapsulation efficiency of QR (>90%). UV and fluorescence spectral characterization indicated the interaction/association of QR with LeciPlex components. Cryo-TEM studies showed that LeciPlex and QR-LeciPlex have a unilamellar structure. SANS confirmed the unilamellar structure of LeciPlex and indicated that the incorporation of QR does not have any effect on the internal structure of the LeciPlex. QR-LeciPlex exhibited significantly higher anti-inflammatory and antitumorigenic activity (p < 0.01) as compared to that of QR suspension on oral administration.

[1]  V. Aswal,et al.  Onion phases of PEG-8 distearate. , 2007, Journal of pharmaceutical sciences.

[2]  L. Pelzer,et al.  Comparative study of flavonoids in experimental models of inflammation. , 2003, Pharmacological research.

[3]  J. Terao,et al.  Combination of lipids and emulsifiers enhances the absorption of orally administered quercetin in rats. , 2002, Journal of agricultural and food chemistry.

[4]  Y. El‐Sayed,et al.  Disposition of the Flavonoid Quercetin in Rats After Single Intravenous and Oral Doses , 2003, Drug development and industrial pharmacy.

[5]  B. Sengupta,et al.  Binding of quercetin with human serum albumin: a critical spectroscopic study. , 2003, Biopolymers.

[6]  Darin Khumsupan,et al.  Apolipoprotein E LDL receptor-binding domain-containing high-density lipoprotein: a nanovehicle to transport curcumin, an antioxidant and anti-amyloid bioflavonoid. , 2011, Biochimica et biophysica acta.

[7]  M. Ramadan.  Quercetin increases antioxidant activity of soy lecithin in a triolein model system , 2008 .

[8]  Dae-Duk Kim,et al.  Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[9]  I. Grillo,et al.  Spontaneous formation of nanovesicles in mixtures of nonionic and dialkyl chain cationic surfactants studied by surface tension and SANS. , 2009, Langmuir : the ACS journal of surfaces and colloids.

[10]  Z. Zuo,et al.  Physicochemical and structural characterization of quercetin-beta-cyclodextrin complexes. , 2005, Journal of pharmaceutical sciences.

[11]  G. Williams,et al.  A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. , 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[12]  Chun-ching Lin,et al.  Preparation, physicochemical characterization, and antioxidant effects of quercetin nanoparticles. , 2008, International journal of pharmaceutics.

[13]  J. Calixto,et al.  Anti-inflammatory effect of quercetin-loaded microemulsion in the airways allergic inflammatory model in mice. , 2010, Pharmacological research.

[14]  B. Yue,et al.  Highly stable phospholipid unilamellar vesicles from spontaneous vesiculation: A DLS and SANS study. , 2005, The journal of physical chemistry. B.

[15]  L. Almásy,et al.  Multilamellarity, structure and hydration of extruded POPC vesicles by SANS , 2006, European Biophysics Journal.

[16]  T. Tsai,et al.  Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[17]  S. Kulkarni,et al.  Protective effect of quercetin on alcohol abstinence-induced anxiety and convulsions. , 2005, Journal of medicinal food.

[18]  S. Benzeno,et al.  Interaction of a Self-Emulsifying Lipid Drug Delivery System with the Everted Rat Intestinal Mucosa as a Function of Droplet Size and Surface Charge , 1998, Pharmaceutical Research.

[19]  Sik Yoon,et al.  The flavonoid quercetin inhibits dimethylnitrosamine‐induced liver damage in rats , 2003, The Journal of pharmacy and pharmacology.

[20]  Makoto Takahashi,et al.  Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin. , 2009, Journal of agricultural and food chemistry.

[21]  H. Hara,et al.  Enteral administration of soyabean lecithin enhanced lymphatic absorption of triacylglycerol in rats , 2003, British Journal of Nutrition.

[22]  Wei Shao,et al.  Formulation optimization and in situ absorption in rat intestinal tract of quercetin-loaded microemulsion. , 2009, Colloids and surfaces. B, Biointerfaces.

[23]  Fu Qiu,et al.  Lecithin-based cationic nanoparticles as a potential DNA delivery system. , 2006, International journal of pharmaceutics.

[24]  F. Ranelletti,et al.  Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential , 2000, International journal of cancer.

[25]  Dandan Han,et al.  An overview of liposome lyophilization and its future potential. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[26]  C. Lehr,et al.  PLGA Nanoparticles Stabilized with Cationic Surfactant: Safety Studies and Application in Oral Delivery of Paclitaxel to Treat Chemical-Induced Breast Cancer in Rat , 2009, Pharmaceutical Research.

[27]  G. Ubeaud‐Séquier,et al.  Quercetin and naringenin transport across human intestinal Caco‐2 cells , 2009 .

[28]  N. A. Tyukavkina,et al.  Ultraviolet absorption of flavonoids VIII. Ionization constants of kaempferol and quercetin , 1975, Chemistry of Natural Compounds.

[29]  T. Walle,et al.  Methylated Flavonoids Have Greatly Improved Intestinal Absorption and Metabolic Stability , 2006, Drug Metabolism and Disposition.

[30]  A. Day,et al.  Experimental determination of octanol-water partition coefficients of quercetin and related flavonoids. , 2005, Journal of agricultural and food chemistry.

[31]  S. Zeisel,et al.  Lecithin and choline in human health and disease. , 2009, Nutrition reviews.

[32]  Dacheng Wu,et al.  Qualitative observation of chemical change rate for quercetin in basic medium characterized by time resolved UV–vis spectroscopy , 2010 .

[33]  G. Zhai,et al.  Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[34]  S. Shin,et al.  Spectroscopic Properties of Quercetin Derivatives, 
Quercetin‐3‐O‐rhamnoside and Quercetin‐3‐O‐rutinoside, in 
Hydro‐organic Mixed Solvents , 2009, Photochemistry and photobiology.

[35]  A. Juvekar,et al.  Decreased B16F10 melanoma growth and impaired tumour vascularization in BDF1 mice with quercetin‐cyclodextrin binary system , 2006, The Journal of pharmacy and pharmacology.

[36]  S. Benita,et al.  Positively charged self-emulsifying oil formulation for improving oral bioavailability of progesterone. , 1996, Pharmaceutical development and technology.

[37]  B. Ye,et al.  Liposomal Quercetin Efficiently Suppresses Growth of Solid Tumors in Murine Models , 2006, Clinical Cancer Research.

[38]  E. Roussakis,et al.  Quercetin exhibits a specific fluorescence in cellular milieu: a valuable tool for the study of its intracellular distribution. , 2007, Journal of agricultural and food chemistry.

[39]  R. Guo,et al.  Interaction of flavonoid, quercetin with organized molecular assemblies of nonionic surfactant , 2006 .

[40]  I. Bala,et al.  Sustained release nanoparticulate formulation containing antioxidant-ellagic acid as potential prophylaxis system for oral administration , 2006, Journal of drug targeting.

[41]  C. Carda,et al.  Dietary administration of high doses of pterostilbene and quercetin to mice is not toxic. , 2009, Journal of agricultural and food chemistry.

[42]  V. Aswal,et al.  Characterization of vesicles from ion-paired gemini surfactants by small angle neutron scattering , 2003 .

[43]  A. Bast,et al.  Health effects of quercetin: from antioxidant to nutraceutical. , 2008, European journal of pharmacology.

[44]  V. Jain,et al.  Preparation and performance evaluation of saquinavir laden cationic submicron emulsions , 2009, Drug delivery.

[45]  Sonia Ramos,et al.  Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. , 2007, The Journal of nutritional biochemistry.

[46]  Tak W. Kee,et al.  Encapsulation of curcumin in cationic micelles suppresses alkaline hydrolysis. , 2008, Langmuir : the ACS journal of surfaces and colloids.